Estrella Immunopharma
ESLA
ESLA
21 hedge funds and large institutions have $29M invested in Estrella Immunopharma in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
21
Holders Change
+2
Holders Change %
+10.53%
% of All Funds
0.33%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
2
Increased
2
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Citigroup
New York
|
$620K |
2 |
Janus Henderson Group
London,
United Kingdom
|
$173K |
3 |
OFG
OTA Financial Group
Purchase,
New York
|
$446K |
4 |
CH
CVI Holdings
Wilmington,
Delaware
|
$1.76M |
Top Sellers
1 |
SSA
Schonfeld Strategic Advisors
New York
|
$113K |
2 |
KIM
Karpus Investment Management
Pittsford,
New York
|
$8.62M |